Article Versions Notes

Zhang P, Zhang Z, Li J, Xu M, Lu W, Chen M, Shi J, Wang Q, Zhang H, Huang S, et al. Advanced PROTAC and Quantitative Proteomics Strategy Reveals Bax Inhibitor-1 as a Critical Target of Icaritin in Burkitt Lymphoma. International Journal of Molecular Sciences. 2024; 25(23):12944. https://doi.org/10.3390/ijms252312944

Zhang, Peixi, Ziqing Zhang, Jie Li, Meng Xu, Weiming Lu, Ming Chen, Jiaqi Shi, Qiaolai Wang, Hengyuan Zhang, Shi Huang, and et al. 2024. "Advanced PROTAC and Quantitative Proteomics Strategy Reveals Bax Inhibitor-1 as a Critical Target of Icaritin in Burkitt Lymphoma" International Journal of Molecular Sciences 25, no. 23: 12944. https://doi.org/10.3390/ijms252312944

Zhang, P., Zhang, Z., Li, J., Xu, M., Lu, W., Chen, M., Shi, J., Wang, Q., Zhang, H., Huang, S., Lian, C., Liu, J., Ma, J., & Liu, J. (2024). Advanced PROTAC and Quantitative Proteomics Strategy Reveals Bax Inhibitor-1 as a Critical Target of Icaritin in Burkitt Lymphoma. International Journal of Molecular Sciences, 25(23), 12944. https://doi.org/10.3390/ijms252312944